Drug profile · INN
cangrelor
KENGREXAL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cangrelor (KENGREXAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN cangrelor
Brand KENGREXAL
Route INTRAVENOUS
Formulation POWDER
ATC code B01
Frequently asked questions
What is cangrelor?
cangrelor (KENGREXAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for cangrelor?
KENGREXAL is a marketed brand name for cangrelor. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cangrelor?
cangrelor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.